Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

iwCLL 2019 | Young Investigator Meeting at iwCLL 2019

Talha Munir • 21 Sep 2019
iwCLL 2019
Chronic Lymphocytic Leukemia Leukemia

Talha Munir, MBBS, Leeds Teaching Hospitals NHS Trust, Leeds, UK, gives his highlights from the young investigator meeting at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

More from Talha Munir

The Phase III STATIC trial: stopping therapy to avoid treatment resistance in CLL 1:30
The Phase III STATIC trial: stopping therapy to avoid treatment resistance in CLL
Talha Munir • 14 Sep 2025
The comparative efficacy of zanubrutinib versus fixed-duration AV in frontline CLL 1:33
The comparative efficacy of zanubrutinib versus fixed-duration AV in frontline CLL
Talha Munir • 14 Sep 2025
MRD-guided ibrutinib-venetoclax versus ibrutinib or FCR for previously untreated CLL: FLAIR trial 1:39
MRD-guided ibrutinib-venetoclax versus ibrutinib or FCR for previously untreated CLL: FLAIR trial
Talha Munir • 14 Sep 2025
Using MRD-driven therapy in CLL: current and future applications 1:33
Using MRD-driven therapy in CLL: current and future applications
Talha Munir • 8 Dec 2024

Related Videos

The value and mission of the International Workshop on Acute Leukemias 14:36
The value and mission of the International Workshop on Acute Leukemias
Charles Craddock et al. • 21 Oct 2025
One big question with Koichi Takahashi: what AML advance could transform frontline care in 3 years? 1:30
One big question with Koichi Takahashi: what AML advance could transform frontline care in 3 years?
Koichi Takahashi • 26 Sep 2025
One big question with Naval Daver: what AML advance could transform frontline care in three years? 1:05
One big question with Naval Daver: what AML advance could transform frontline care in three years?
Naval Daver • 26 Sep 2025
One big question with Charles Craddock: what AML advance could transform frontline care in 3 years? 3:13
One big question with Charles Craddock: what AML advance could transform frontline care in 3 years?
Charles Craddock • 26 Sep 2025
The content of VJHemOnc is intended for healthcare professionals